Difficulty: Medium
Average Score: 67%
Practice
The antihypertensive drug most likely to aggravate angina pectoris is
Correct answer
C
Rationale
In this question, the correct answer is C) Hydralazine.
Hydralazine is a direct-acting vasodilator that works by relaxing the smooth muscles of blood vessels. Although it is effective in lowering blood pressure, it can cause reflex tachycardia due to its vasodilatory effects. This increased heart rate can potentially worsen angina pectoris, a condition characterized by chest pain or discomfort caused by reduced blood flow to the heart.
A) Clonidine is an antihypertensive drug that works by stimulating alpha-2 adrenergic receptors in the brain to reduce sympathetic outflow, thus decreasing heart rate and blood pressure. It is not known to aggravate angina pectoris.
B) Guanethidine is a sympatholytic drug that blocks the release of norepinephrine from sympathetic nerve endings, leading to decreased blood pressure. It is not commonly associated with aggravating angina pectoris.
D) Methyldopa is a centrally acting alpha-2 adrenergic agonist that reduces sympathetic outflow, similar to clonidine. It is not typically known to exacerbate angina pectoris.
Educational context: Understanding the interactions between different drug classes and their potential effects on various physiological systems is crucial in pharmacology. In this case, recognizing the impact of vasodilators on heart rate and angina symptoms is important in selecting appropriate antihypertensive therapy for patients with underlying cardiovascular conditions.
Hydralazine is a direct-acting vasodilator that works by relaxing the smooth muscles of blood vessels. Although it is effective in lowering blood pressure, it can cause reflex tachycardia due to its vasodilatory effects. This increased heart rate can potentially worsen angina pectoris, a condition characterized by chest pain or discomfort caused by reduced blood flow to the heart.
A) Clonidine is an antihypertensive drug that works by stimulating alpha-2 adrenergic receptors in the brain to reduce sympathetic outflow, thus decreasing heart rate and blood pressure. It is not known to aggravate angina pectoris.
B) Guanethidine is a sympatholytic drug that blocks the release of norepinephrine from sympathetic nerve endings, leading to decreased blood pressure. It is not commonly associated with aggravating angina pectoris.
D) Methyldopa is a centrally acting alpha-2 adrenergic agonist that reduces sympathetic outflow, similar to clonidine. It is not typically known to exacerbate angina pectoris.
Educational context: Understanding the interactions between different drug classes and their potential effects on various physiological systems is crucial in pharmacology. In this case, recognizing the impact of vasodilators on heart rate and angina symptoms is important in selecting appropriate antihypertensive therapy for patients with underlying cardiovascular conditions.